E
Overview
EnviroLogix develops and manufactures testing solutions for detecting GMOs, mycotoxins, plant pathogens, natural toxins, and chemical contaminants in agricultural samples. Its products use DNA-based detection with the DNAble isothermal amplification technology, enabling rapid, field-friendly diagnostics without complex thermal cycling. The company combines broad target coverage with a patented DNA detection platform and a global presence to support testing across multiple matrices. Its goal is to provide reliable, rapid diagnostic solutions that help ensure safety and compliance in agriculture.
Work here?Claim your company
Simplify's take
What believers are saying
- September 2026 Alltech partnership expands distribution into feed mills and livestock operations.
- November 2025 and 2026 hiring signals operational investment, not retrenchment, at Portland.
- Scott Menke’s 2026 presidency brings Danaher and Fortive operating discipline into commercialization.
What critics are saying
- EnviroLogix still depends on grain and feed customers; crop downturns hit ordering fast.
- Thermo Fisher, Neogen, and Eurofins can bundle lab, software, and service contracts.
- If RAPIREAD adoption stalls, EnviroLogix remains a commodity strip vendor with weak software leverage.
What makes EnviroLogix unique
- Patented DNAble lets EnviroLogix run field-friendly molecular diagnostics without lab infrastructure.
- QuickScan reads GMO and mycotoxin tests on one platform, simplifying on-site workflows.
- September 18, 2026 Alltech integration embeds EnviroLogix results inside RAPIREAD analytics.
Help us improve and share your feedback! Did you find this helpful?